+65 63464191 info@healthytimes.com.sg
Health Magazine Singapore l Singapore Health Magazine l Healthy Times Magazine
  • Home
  • Health
  • Fitness
  • Beauty
  • Food & Nutrition
  • Green Living
  • Kids & Women
  • Disease and Prevention
  • Well Being
  • Events
  • Bahasa
Select Page

J INTS BIO Reports Fourth-Generation EGFR Inhibitor JIN-A02 in Clinical Cancer Research

by | PRNewswire Asia

SEOUL, South Korea, Feb. 12, 2026 /PRNewswire/ — J INTS BIO, Inc. announced that research findings on its investigational fourth-generation EGFR tyrosine kinase inhibitor (TKI), JIN-A02, have been published in Clinical Cancer Research, a leading oncology journal...

AIA Singapore surpasses S$40 Billion in payouts over the last decade

by | PRNewswire Asia

Commemorating its 95th anniversary, the insurer reinforces its role as a vital safety net and wealth partner with new initiatives to fulfil promises across healthcare and long-term financial goals...

CJ Foods Names Adam Ricciardone as Global Chief Technology Officer to Drive Global Growth and Innovation

by | PRNewswire Asia

SEOUL, South Korea, Feb. 11, 2026 /PRNewswire/ — CJ Foods, a global leader in Korean, Asian and American cuisine, and the food business unit of CJ CheilJedang, today announced the appointment of Adam Ricciardone as its new Global Chief Technology Officer (CTO)....

Canadian Solar Delivers Its First Grid-Connected Battery Energy Storage System in Japan

by | PRNewswire Asia

KITCHENER, ON, Feb. 11, 2026 /PRNewswire/ — Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that e-STORAGE, its energy storage solutions business, has delivered its first grid-connected battery...

Akeso's IL-4Rα/ST2 Bispecific Antibody Cleared for Seven Phase II Studies in China Spanning Respiratory and Autoimmune Indications

by | PRNewswire Asia

HONG KONG, Feb. 11, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) is pleased to announce that the National Medical Products Administration has approved the initiation of Phase II clinical trials for AK139,  a first-in-class IL-4Rα/ST2-targeting bispecific...

PharmaResearch Announces Supply Agreement for Rejuran in Brazil

by | PRNewswire Asia

SEONGNAM, South Korea, Feb. 11, 2026 /PRNewswire/ — PharmaResearch Co., Ltd. (CEO Jihoon Sohn), a leading regenerative medicine company, announced that it has entered into an exclusive supply agreement for Rejuran with DermaDream, a Brazilian aesthetic company,...
« Older Entries
Next Entries »
  • Beauty
  • Disease and Prevention
  • Events
  • Fitness
  • Food and Nutrition
  • Green Living
  • Health
  • Kids and Women
  • News
  • Well Being

PRNewswire Asia

Sitemap

Links

editor@healthytimes.com.sg

editor@healthytimes.com.sg (Press Release)

Phone:+65 63464191

  • Facebook
© Copyright healthytimes.com.sg